Form 8-K - Current report:
SEC Accession No. 0001641172-25-016833
Filing Date
2025-06-27
Accepted
2025-06-27 11:50:48
Documents
13
Period of Report
2025-06-26
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42408
2 EX-16.1 ex16-1.htm EX-16.1 5025
  Complete submission text file 0001641172-25-016833.txt   209794

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE clcs-20250626.xsd EX-101.SCH 3023
4 XBRL LABEL FILE clcs-20250626_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE clcs-20250626_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3346
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55413 | Film No.: 251083963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)